TY  - JOUR
T1  - The effect of obesity on prognosis in patients with endometrioid type endometrial adenocarcinoma
TT  - Obezitenin endometrioid tip endometrial adenokarsinomlu hastalarda prognoza etkisi
AU  - Gül, Özcan
AU  - Demirağ, Guzin
PY  - 2025
DA  - May
Y2  - 2025
DO  - 10.32322/jhsm.1658483
JF  - Journal of Health Sciences and Medicine
JO  - J Health Sci Med /JHSM /jhsm
PB  - MediHealth Academy Yayıncılık
WT  - DergiPark
SN  - 2636-8579
SP  - 383
EP  - 388
VL  - 8
IS  - 3
LA  - en
AB  - Aims: This study sought to investigate the relationship between pre-treatment body-mass index (BMI) and established prognostic factors associated with endometrial cancer, as well as to assess its impact on survival in patients diagnosed with this malignancy.Methods: Patients diagnosed with endometrioid-type endometrial cancer between January 2000 and June 2010 at the medical oncology clinic, and who received treatment and follow-up at our clinic, were included in the study. The patient files and the hospital electronic database were retrospectively reviewed. The patients were divided into non-obese (BMI
KW  - Endometrial cancer
KW  - obesity
KW  - survival
N2  - Amaçlar: Bu çalışmada, tedavi öncesi vücut kitle indeksi (VKİ) ile endometrial kanserle ilişkili, belirlenmiş prognostik faktörler arasındaki ilişki araştırıldı ve bu malignite tanısı konulan hastalarda sağ kalım üzerindeki etkisi değerlendirildi.Yöntemler: Ocak 2000 ile Haziran 2010 arasında tıbbi onkoloji kliniğinde endometrioid tip endometrial kanser tanısı konulan ve tedavisi ve takibi kliniğimizde devam eden hastalar çalışmaya dahil edildi. Hasta dosyaları ve hastane elektronik veri tabanı retrospektif olarak incelendi. Hastalar obez olmayan (VKİ
CR  - Shaw E, Farris M, McNeil J, Friedenreich C. Obesity and endometrial cancer. Recent Results Cancer Res. 2016;208:107-136. doi:10.1007/978-3-319-42542-9_7
CR  - Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. doi:10. 3322/CAAC.21660
CR  - Hopkins BD, Goncalves MD, Cantley LC. Journal of clinical oncology obesity and cancer mechanisms: cancer metabolism. J Clin Oncol. 2016; 34:4277-4283. doi:10.1200/JCO.2016.67.9712
CR  - Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG. Body-mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;19(12):3119-3130. doi:10.1158/1055-9965.EPI-10-0832
CR  - Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review 1. Accessed August 17, 2024. http://aacrjournals.org/cebp/article-pdf/11/12/1531/2261619/ce120200 1531.pdf
CR  - Hazelwood E, Sanderson E, Tan VY, et al. Identifying molecular mediators of the relationship between body-mass index and endometrial cancer risk: a Mendelian randomization analysis. BMC Med. 2022;20(1):125. doi:10.1186/s12916-022-02322-3
CR  - Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N. Endometrial cancer. Lancet. 2022;399(10333):1412-1428. doi: 10.1016/S0140-6736(22)00323-3
CR  - Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569-578. doi: 10.1016/S0140-6736(08)60269-X
CR  - Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625-1638. doi:10.1056/NEJMoa 021423
CR  - Arem H, Chlebowski R, Stefanick ML, et al. Body-mass index, physical activity, and survival after endometrial cancer diagnosis: results from the women’s health initiative. Gynecol Oncol. 2013;128(2):181-186. doi: 10.1016/J.YGYNO.2012.10.029
CR  - Arem H, Park Y, Pelser C, et al. Prediagnosis body-mass index, physical activity, and mortality in endometrial cancer patients. J Natl Cancer Inst. 2013;105(5):342-349. doi:10.1093/JNCI/DJS530
CR  - Chia VM, Newcomb PA, Trentham-Dietz A, Hampton JM. Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis. Int J Gynecol Cancer. 2007;17(2):441-446. doi:10.1111/J. 1525-1438.2007.00790.X
CR  - Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body-mass index in the million women study: cohort study. BMJ. 2007;335(7630):1134-1139. doi:10.1136/BMJ. 39367.495995.AE
CR  - Von Gruenigen VE, Tian C, Frasure H, Waggoner S, Keys H, Barakat RR. Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: a gynecologic oncology group study. Cancer. 2006;107(12):2786-2791. doi:10.1002/CNCR.22351
CR  - AkbayIr O, CorbacIoglu Esmer A, Numanoglu C, et al. Influence of body-mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer. Arch Gynecol Obstet. 2012;286(5):1269-1276. doi:10.1007/S00404-012-2431-2
CR  - Crosbie EJ, Roberts C, Qian W, Swart AM, Kitchener HC, Renehan AG. Body-mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trial. Eur J Cancer. 2012;48(6):853-864. doi:10.1016/J.EJCA.2011.10.003
CR  - Jeong NH, Lee JM, Lee JK, et al. Role of body-mass index as a risk and prognostic factor of endometrioid uterine cancer in Korean women. Gynecol Oncol. 2010;118(1):24-28. doi:10.1016/J.YGYNO.2010.03.001
CR  - Kodama J, Seki N, Ojima Y, Nakamura K, Hongo A, Hiramatsu Y. Correlation of presenting symptoms and patient characteristics with endometrial cancer prognosis in Japanese women. Int J Gynaecol Obstet. 2005;91(2):151-156. doi:10.1016/J.IJGO.2005.08.002
CR  - Martra F, Kunos C, Gibbons H, et al. Adjuvant treatment and survival in obese women with endometrial cancer: an international collaborative study. Am J Obstet Gynecol. 2008;198(1):89.e1-89.e8. doi:10.1016/J.AJOG.2007.06.023
CR  - Münstedt K, Wagner M, Kullmer U, Hackethal A, Franke FE. Influence of body-mass index on prognosis in gynecological malignancies. Cancer Causes Control. 2008;19(9):909-916. doi:10.1007/S10552-008-9152-7
CR  - Temkin SM, Pezzullo JC, Hellmann M, Lee YC, Abulafia O. Is body-mass index an independent risk factor of survival among patients with endometrial cancer? Am J Clin Oncol. 2007;30(1):8-14. doi:10.1097/01.COC.0000236047.42283.B8
CR  - Everett E, Tamimi H, Greer B, et al. The effect of body-mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol. 2003;90(1):150-157. doi:10.1016/S0090-8258(03)00232-4
CR  - Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia. 2007;50(7):1365-1374. doi:10.1007/S00125-007-0681-5
CR  - Fader AN, Arriba LN, Frasure HE, von Gruenigen VE. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol. 2009;114(1):121-127. doi:10.1016/J.YGYNO. 2009.03.039
CR  - Secord AA, Hasselblad V, Von Gruenigen VE, et al. Body-mass index and mortality in endometrial cancer: a systematic review and meta-analysis. Gynecol Oncol. 2016;140(1):184-190. doi:10.1016/j.ygyno.2015.10.020
CR  - Sorosky JI. Endometrial cancer. Obstetrics Gynecol. 2012;120(2 Pt 1): 383-397. doi:10.1097/AOG.0B013E3182605BF1
CR  - Karateke A, Selçuk S, Asoğlu MR, et al. Endometrium kanserinde sağkalımı etkileyen prognostik faktörler. Turk Jinekol Obstetrik Dern Derg. 2012;9(1):42-46. doi:10.5505/TJOD.2012.83435
CR  - Park JY, Cho JH, Min JY, et al. Impact of body-mass index on the prognosis of Korean women with endometrioid adenocarcinoma of the uterus: a cohort study. Obstet Gynecol Sci. 2014;57(2):115. doi:10.5468/OGS.2014.57.2.115
CR  - Gates EJ, Hirschfield L, Matthews RP, Yap OW. Body-mass index as a prognostic factor in endometrioid adenocarcinoma of the endometrium. J Natl Med Assoc. 2006;98(11):1814-1822.
UR  - https://doi.org/10.32322/jhsm.1658483
L1  - https://dergipark.org.tr/en/download/article-file/4693302
ER  -